S&T Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
S&T Bank's PFE Position: Q2 2026 in Review
S&T Bank increased its Pfizer (PFE) stake by 314% in Q2 2026, buying an estimated $108K and bringing the position to 5,442 shares worth $131K. The position accounts for 0.04% of the portfolio, ranked #131.
S&T Bank first reported a position in PFE in Q2 2013 and has held it in 11 quarters since. The position peaked at $220K in Q2 2013. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- S&T Bank held 5,442 shares of Pfizer worth $131K as of Q2 2026.
- S&T Bank bought 4,128 Pfizer shares in Q2 2026, an estimated $108K.
- Pfizer made up 0.04% of S&T Bank's portfolio in Q2 2026, its #131 holding.
- S&T Bank first reported a position in Pfizer in Q2 2013 and has held it in 11 quarters since.
- S&T Bank's Pfizer position peaked at $220K in Q2 2013.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.